Simi Valley, CA, United States of America

David Michael Wagenbach

This inventor holds 18 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 11 EPO patents, primarily in Implantable Stimulator Technology. Top assignee: Boston Scientific Neuromodulation Corporation. Active years: 2020-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Michael Wagenbach. Retrieved from https://idiyas.com/inventor/david-michael-wagenbach

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 18 

% Patents Active = 100.0


 

Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2020-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Implantable Stimulator
Waveform Generation
Neural Sensing
Current Steering
Pulse Definition Circuitry
Amplitude Modulation
Charge Recovery
Evoked Potentials
Medical Device Architecture
Analog Measurement
18 patents (USPTO):Explore Patents

Title: David Michael Wagenbach: Innovator in Implantable Stimulation Technology

Introduction

David Michael Wagenbach is a prominent inventor based in Simi Valley, California. He has made significant contributions to the field of neuromodulation, holding a total of 16 patents. His work primarily focuses on developing advanced technologies for implantable stimulators, which have the potential to improve therapeutic outcomes for patients.

Latest Patents

Wagenbach's latest patents include innovative designs for pulse definition circuitry in implantable pulse generators. This technology enhances stimulation circuitry by incorporating memory circuitry that stores pulse programs, steering programs, and aggregate programs. These programs work together to define pulse shapes and electrode configurations, allowing for precise control of stimulation delivered by the device. Another notable patent involves techniques for neural sensing in implantable stimulators during passive charge recovery. This method allows for the sensing of neural responses, such as Evoked Compound Action Potentials (ECAPs), during a high-impedance passive charge recovery phase, optimizing the timing and effectiveness of the stimulation.

Career Highlights

Wagenbach is currently employed at Boston Scientific Neuromodulation Corporation, where he continues to innovate in the field of medical technology. His extensive experience and expertise have positioned him as a key player in the development of advanced neuromodulation devices.

Collaborations

Throughout his career, Wagenbach has collaborated with notable colleagues, including Philip Leonard Weiss and Goran Nils Marnfeldt. These partnerships have contributed to the advancement of technologies in the neuromodulation sector.

Conclusion

David Michael Wagenbach's contributions to implantable stimulation technology demonstrate his commitment to improving patient care through innovation. His patents reflect a deep understanding of the complexities involved in neuromodulation, and his work continues to influence the field significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…